Rapid hematological responses improve outcomes in patients with very advanced (Stage IIIb) cardiac immunoglobulin light chain amyloidosis.

Rapid hematological responses improve outcomes in patients with very advanced (Stage IIIb) cardiac immunoglobulin light chain amyloidosis. Haematologica. 2018 Jan 05;: Authors: Manwani R, Foard D, Mahmood S, Sachchithanantham S, Lane T, Quarta C, Youngstein T, Rezk T, Lachmann HJ, Gillmore JD, Fontana M, Whelan C, Hawkins PN, Wechalekar AD PMID: 29305414 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29305414?dopt=Abstract

Source: Haematologica - January 5, 2018 Category: Hematology Authors: Manwani R, Foard D, Mahmood S, Sachchithanantham S, Lane T, Quarta C, Youngstein T, Rezk T, Lachmann HJ, Gillmore JD, Fontana M, Whelan C, Hawkins PN, Wechalekar AD Tags: Haematologica Source Type: research

More News: Amyloidosis | Hematology